Chromadex Corp

NASDAQ:CDXC   3:59:55 PM EDT
9.51
+0.09 (+0.96%)
Equity Financing / Related

ChromaDex Shares Research Findings From The Chromadex External Research Program

Published: 06/16/2021 11:49 GMT
Chromadex Corp (CDXC) - Chromadex Shares Research Findings From the Chromadex External Research Program (cerp™).
Chromadex Corp - New Preclinical Research in Mice Finds Nicotinamide Riboside (nr) Prevented Loss of Bone Mass, Reduced Neuroinflammation.
Chromadex Corp - a New in Vitro Study Demonstrated That Nr Reduced Harmful Effects of Alcohol on Macrophages.